Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study

Bibliographic Details
Title: Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study
Authors: Ornstein, Moshe C *, Pal, Sumanta K, Wood, Laura S, Tomer, Jackie M, Hobbs, Brian P, Jia, Xuefei S, Allman, Kimberly D, Martin, Allison, Olencki, Thomas, Davis, Nancy B, Gilligan, Timothy D, Mortazavi, Amir, Rathmell, W Kimryn, Garcia, Jorge A, Rini, Brian I
Source: In The Lancet Oncology October 2019 20(10):1386-1394
Database: ScienceDirect
More Details
ISSN:14702045
DOI:10.1016/S1470-2045(19)30513-3
Published in:The Lancet Oncology
Language:English